sleeper: "Abbott may use the technology for diagnosis of cancer across the board and is not limited to just the prostate. That is good news!"
I am surprised Terry Johnston had to refer to Dr. Moro to answer that question. It tends to show he has not read the filings on BOCX. BTW, I would never have invested in the company if the technology licensed to Abbott was restricted to the prostate.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.